OVID קפיטליזציה חשבונאית Ovid Therapeutics Inc

The price history of Ovid Therapeutics Inc. (OVID) on the GURU.Markets platform is currently at 0.21. Ovid Therapeutics Inc. (OVID) minimizes environmental impact through energy efficiency and waste purification in its laboratories. The business relies on the development of unique enzyme preparations for the treatment of epilepsy, establishing a closed network of loyal patients. Meanwhile, the development of American science remains stable, as the humanitarian status of medicine precludes the influence of trade conflicts.

The development of Ovid Therapeutics Inc. (OVID) depends on the success of clinical phases and partnership payments, which directly impact the volume of equity on the balance sheet. This metric, representing the sum of net assets minus liabilities, determines the real financial stability and the pace of business recovery. A local decline in this indicator may signal risks, whereas its growth confirms the reliability of capitalization.